Tri-Clustering Analysis for Dissecting Epigenetic Patterns Across Multiple Cancer Types

被引:2
|
作者
Gan, Yanglan [1 ]
Dong, Zhiyuan [1 ]
Zhang, Xia [2 ]
Zou, Guobing [2 ]
机构
[1] Donghua Univ, Sch Comp Sci & Technol, Shanghai, Peoples R China
[2] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Tri-clustering; Epigenetic pattern; Pan-cancer; EPIGENOME; DYNAMICS; GASC1; GENE;
D O I
10.1007/978-3-319-95933-7_40
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Tumor cells not only harbor genetic and epigenetic alterations, but also are regulated by various epigenetic modifications. Identification of tumor epigenetic similarities across different cancer types is useful for the discovery of treatments that can be extended to different cancers. Nowadays, abundant epigenetic modification profiles have provided good opportunity to achieve this goal. Here, we proposed a tri-clustering approach for integrative pan-cancer epigenomic analysis, named TriPCE. We applied TriPCE to uncover epigenetic mode among seven cancer types. This approach can identify significant cross-cancer epigenetic modification similarities. The associated gene analysis demonstrates strong relevance with cancer development and reveals consistent tendency among cancer types.
引用
收藏
页码:330 / 336
页数:7
相关论文
共 50 条
  • [31] Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
    Kumar, Runjun D.
    Bose, Ron
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Frequency and molecular fingerprints of microsatellite instability across multiple cancer types
    Khammad, V.
    Arkhipov, A.
    Nikitin, I.
    Abramov, I.
    Khammad, E.
    Filimonov, M.
    Zhuchenko, N.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 445 - 445
  • [33] Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types
    Runjun D. Kumar
    Ron Bose
    Scientific Reports, 7
  • [34] Systematic analysis of the predictive gene expression signatures of immunotherapies across multiple cancer types using IOSig
    Coleman, Samuel
    Wheeler, Caroline
    Hoyd, Rebecca
    Denko, Louis
    Lin, Ching-Nung
    Fadlullah, Muhammad Z.
    Hu-Lieskovan, Siwen
    Chung, Christine
    Tarhini, Ahmad A.
    Spakowicz, Daniel
    Tan, Aik Choon
    CANCER RESEARCH, 2023, 83 (07)
  • [35] Mapping the experiences of people with advanced cancer across multiple cancer types—a scoping review
    Steve E. Kalloger
    Cheryl Ho
    Craig Mitton
    Dean A. Regier
    Journal of Cancer Survivorship, 2024, 18 : 318 - 324
  • [36] The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis
    Cao, Jinlong
    Yang, Xin
    Chen, Siyu
    Wang, Jirong
    Fan, Xinpeng
    Fu, Shengjun
    Yang, Li
    TRANSLATIONAL ONCOLOGY, 2022, 20
  • [37] Genetic variants in epigenetic pathways and risk of multiple cancer types in the GAME-ON consortium
    Scherer, Dominique
    Toth, Reka
    Kelemen, Linda
    Risch, Angela
    Hazra, Aditi
    Issa, Jean Pierre
    Moreno, Victor
    Eeles, Rosalind A.
    Quackenbush, John
    Goode, Ellen L.
    Ogino, Shuji
    Hung, Rayjean
    Urich, Cornelia M.
    CANCER RESEARCH, 2015, 75
  • [38] Patterns and functional implications of rare germline variants across 12 cancer types
    Lu, Charles
    Xie, Mingchao
    Wendl, Michael C.
    Wang, Jiayin
    McLellan, Michael D.
    Leiserson, Mark D. M.
    Huang, Kuan-lin
    Wyczalkowski, Matthew A.
    Jayasinghe, Reyka
    Banerjee, Tapahsama
    Ning, Jie
    Tripathi, Piyush
    Zhang, Qunyuan
    Niu, Beifang
    Ye, Kai
    Schmidt, Heather K.
    Fulton, Robert S.
    McMichael, Joshua F.
    Batra, Prag
    Kandoth, Cyriac
    Bharadwaj, Maheetha
    Koboldt, Daniel C.
    Miller, Christopher A.
    Kanchi, Krishna L.
    Eldred, James M.
    Larson, David E.
    Welch, John S.
    You, Ming
    Ozenberger, Bradley A.
    Govindan, Ramaswamy
    Walter, Matthew J.
    Ellis, Matthew J.
    Mardis, Elaine R.
    Graubert, Timothy A.
    Dipersio, John F.
    Ley, Timothy J.
    Wilson, Richard K.
    Goodfellow, Paul J.
    Raphael, Benjamin J.
    Chen, Feng
    Johnson, Kimberly J.
    Parvin, Jeffrey D.
    Ding, Li
    NATURE COMMUNICATIONS, 2015, 6
  • [39] Patterns and functional implications of rare germline variants across 12 cancer types
    Charles Lu
    Mingchao Xie
    Michael C. Wendl
    Jiayin Wang
    Michael D. McLellan
    Mark D. M. Leiserson
    Kuan-lin Huang
    Matthew A. Wyczalkowski
    Reyka Jayasinghe
    Tapahsama Banerjee
    Jie Ning
    Piyush Tripathi
    Qunyuan Zhang
    Beifang Niu
    Kai Ye
    Heather K. Schmidt
    Robert S. Fulton
    Joshua F. McMichael
    Prag Batra
    Cyriac Kandoth
    Maheetha Bharadwaj
    Daniel C. Koboldt
    Christopher A. Miller
    Krishna L. Kanchi
    James M. Eldred
    David E. Larson
    John S. Welch
    Ming You
    Bradley A. Ozenberger
    Ramaswamy Govindan
    Matthew J. Walter
    Matthew J. Ellis
    Elaine R. Mardis
    Timothy A. Graubert
    John F. Dipersio
    Timothy J. Ley
    Richard K. Wilson
    Paul J. Goodfellow
    Benjamin J. Raphael
    Feng Chen
    Kimberly J. Johnson
    Jeffrey D. Parvin
    Li Ding
    Nature Communications, 6
  • [40] Strongly preserved modules between cancer tissue and cell line contribute to drug resistance analysis across multiple cancer types
    Dong, Siyao
    Song, Chengyan
    Qi, Baocui
    Jiang, Xiaochen
    Liu, Lu
    Xu, Yan
    GENOMICS, 2021, 113 (03) : 1026 - 1036